α-Melanocyte-stimulating hormone
α-Melanocyte-stimulating hormone (α-MSH) is a peptide hormone of the melanocortin family, which is involved in various physiological functions, including the regulation of skin pigmentation, appetite, and energy homeostasis. It is derived from the proopiomelanocortin (POMC) precursor molecule and is produced primarily in the pituitary gland.
Structure and Synthesis[edit]

α-MSH is a tridecapeptide, meaning it is composed of 13 amino acids. It is synthesized from the larger precursor protein, proopiomelanocortin (POMC), through a series of enzymatic cleavages. The POMC gene is expressed in the anterior pituitary, hypothalamus, and other tissues. The processing of POMC to α-MSH involves the action of prohormone convertases, which cleave POMC into several active peptides, including α-MSH, adrenocorticotropic hormone (ACTH), and others.
Function[edit]
α-MSH plays a crucial role in the regulation of skin pigmentation. It exerts its effects by binding to the melanocortin 1 receptor (MC1R) on melanocytes, stimulating the production and release of melanin, the pigment responsible for skin and hair color. This process is part of the body's response to ultraviolet radiation exposure, leading to tanning.
In addition to its role in pigmentation, α-MSH is involved in the regulation of appetite and energy balance. It acts on the melanocortin 4 receptor (MC4R) in the hypothalamus to suppress appetite and increase energy expenditure. This function is part of the complex neuroendocrine system that maintains body weight and energy homeostasis.
Clinical Significance[edit]
Mutations in the MC1R gene can lead to variations in skin and hair color and are associated with an increased risk of melanoma, a type of skin cancer. Additionally, defects in the melanocortin system, particularly involving the MC4R, are linked to obesity and metabolic disorders.
α-MSH and its analogs are being studied for their potential therapeutic applications in conditions such as obesity, inflammatory diseases, and skin disorders. Synthetic analogs of α-MSH, such as afamelanotide, are used in the treatment of certain skin conditions like erythropoietic protoporphyria.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian